Garrett Gruener - Nanomix Founder Chairman

Insider

Garrett Gruener is Founder Chairman of Nanomix
Age 66
Phone510 428 5300
Webhttps://nano.com

Nanomix Management Efficiency

The company has return on total asset (ROA) of (2.5989) % which means that it has lost $2.5989 on every $100 spent on assets. This is way below average. Nanomix's management efficiency ratios could be used to measure how well Nanomix manages its routine affairs as well as how well it operates its assets and liabilities.
Nanomix currently holds 3.62 M in liabilities. Nanomix has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nanomix until it has trouble settling it off, either with new capital or with free cash flow. So, Nanomix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nanomix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nanomix to invest in growth at high rates of return. When we think about Nanomix's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Jeremy HaydenSight Sciences
54
Keith SimeoneSTRATA Skin Sciences
N/A
Lotta BusCellink AB
53
Harold MDNanoVibronix
70
Karin DanielssonCellink AB
41
Chad ClouseAurora Spine
N/A
William MBASTRATA Skin Sciences
58
Stephen DenaroAnteris Technologies
N/A
MBA BSSight Sciences
N/A
John LiuSight Sciences
N/A
M HarrisonNanoVibronix
N/A
Michael GoodmanSTRATA Skin Sciences
N/A
MPH MDAnteris Technologies
N/A
Laszlo GaramszegiAurora Spine
52
Stacie RodgersSight Sciences
N/A
Paul BadawiSight Sciences
49
Robert MocciaSTRATA Skin Sciences
65
Sam ParkSight Sciences
63
CPA CPANanoVibronix
68
John OrdwaySight Sciences
N/A
Jesse SelnickSight Sciences
N/A
Nanomix Corporation develops mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments. Nanomix Corporation was founded in 2000 and is headquartered in San Leandro, California. Nanomix Corp operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 25 people. Nanomix [NNMX] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Nanomix Leadership Team

Elected by the shareholders, the Nanomix's board of directors comprises two types of representatives: Nanomix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanomix. The board's role is to monitor Nanomix's management team and ensure that shareholders' interests are well served. Nanomix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanomix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Vidur Sahney, Chief Officer
Thomas Schlumpberger, CEO Director
David Ludvigson, President, CFO
John Hardesky, Chief Officer
Garrett Gruener, Founder Chairman
Casey JD, Co Sec

Nanomix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nanomix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Nanomix Pink Sheet Analysis

When running Nanomix's price analysis, check to measure Nanomix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanomix is operating at the current time. Most of Nanomix's value examination focuses on studying past and present price action to predict the probability of Nanomix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanomix's price. Additionally, you may evaluate how the addition of Nanomix to your portfolios can decrease your overall portfolio volatility.